Curcuma Extract Beneficial for Muscle Damage
Beneficial Effect of Curcuma Extract In Muscle Damage (Study in Soccer Athlete): Randomized Clinical Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
Muscle damage and inflammation is a clinical problem caused by the unimpeachable body adaptation of strenuous exercise through increasing free radicals. Antioxidants content in Curcuma is hypothesized to alleviate the free radicals. This study aimed to examine the effect of Curcuma extract in the form of ice cream to improve muscle damage and inflammation of soccer athletes caused by strenuous exercise. This study was experimental study with pre-post control group design. Male soccer athlete (n=20) were divided into treatment group (n=10) and control group (n=10). The treatment group was treated by Curcuma extract ice cream for 21 days. Blood samples of creatine kinase (as muscle damage marker) and IL-6 (as inflammation marker) were quantified.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2019
CompletedFirst Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 19, 2020
CompletedJune 19, 2020
June 1, 2020
3 months
June 11, 2020
June 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Lactic acid change
Change from baseline lactic acid at 21 days taken in the lab from venous blood specimen using spectrophotometric method
21 days
Hemoglobin change
Change from baseline hemoglobin at 21 days taken in the lab from venous blood specimen using cyanmethemoglobin method
21 days
IL-6 change
Change from baseline IL-6 at 21 days taken in the lab from venous blood specimen using ELISA method
21 days
Creatinine kinase change
Change from baseline creatinine kinase at 21 days taken in the lab from venous blood specimen using ELISA method
21 days
Study Arms (2)
Control Group
PLACEBO COMPARATORtreated by ice cream without any Curcuma extract supplementation
Treatment Group
EXPERIMENTALtreated by ice cream supplemented by Curcuma extract
Interventions
Eligibility Criteria
You may qualify if:
- male
- year-old
- does not have an acute and chronic
- hemoglobin level ≥13 g/L
- nutrition status normal (BMI \>18.5-25.0)
- no coffee consumption
- no alcohol consumption
- no drugs consumption
- no smoking
- no vitamin and other supplements consumption at least two weeks before this study was conducted
- no additional exercise except the programmed exercise
You may not qualify if:
- Subject did not comply the procedure of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Badan Pusat Pendidikan dan Pelatihan Olahraga Pelajar (BPPLOP) Semarang, Indonesia
Semarang, Provinsi, 50198, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Rosidi, Doctor
Universitas Muhammadiyah Semarang
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dean of Faculty of Nursing and Health, Universitas Muhammadiyah Semarang
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 19, 2020
Study Start
April 8, 2019
Primary Completion
July 8, 2019
Study Completion
July 29, 2019
Last Updated
June 19, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share